Cognitive Impairment in Chronic Obstructive Pulmonary Disease and Chronic Heart Failure: A Systematic Review and Meta-analysis of Observational Studies
- Submitting institution
-
Manchester Metropolitan University
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 2527
- Type
- D - Journal article
- DOI
-
10.1016/j.jamda.2017.01.014
- Title of journal
- Journal of the American Medical Directors Association
- Article number
- -
- First page
- 451.e1
- Volume
- 18
- Issue
- 5
- ISSN
- 1525-8610
- Open access status
- Not compliant
- Month of publication
- March
- Year of publication
- 2017
- URL
-
https://doi.org/10.1016/j.jamda.2017.01.014
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
4
- Research group(s)
-
H - Physiotherapy
- Citation count
- 35
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- This is the first systematic review and meta-analysis to investigate the prevalence of mild cognitive impairment (MCI) in people with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Heart Failure (CHF). The findings revealed that approximately 1 in 4 people with COPD and 1 in 3 people with CHF were reported as having MCI. The paper also showed that the overall prevalence of any cognitive impairment (ACI) in people with COPD and CHF was 32% and 30%, respectively. Therefore, the review showed that MCI and poorer cognitive performances are common in patients with COPD and CHF. Thus, the paper concluded that routine screening for decline in cognitive performance in both CHF and COPD are necessary in order to detect and treat appropriately and to improve concurrent management of both conditions.
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
